Target Name: OR7E155P
NCBI ID: G403297
Review Report on OR7E155P Target / Biomarker Content of Review Report on OR7E155P Target / Biomarker
OR7E155P
Other Name(s): olfactory receptor family 7 subfamily E member 155 pseudogene | Olfactory receptor family 7 subfamily E member 155 pseudogene

OR7E155P: A Potential Drug Target and Biomarker

OR7E155P, a member of the Olfactory Receptor Family 7 (OR7E), has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. OR7E155P is a pseudogene, which means it encodes a gene that does not have a functional RNA molecule but can still trigger an immune response. The OR7E155P gene has been shown to be involved in the development and progression of several neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and major depressive disorder.

The Olfactory Receptor Family 7 (OR7E) is a subfamily of G protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play an important role in cellular signaling. OR7E155P is a member of the OR7E subfamily, which is characterized by the presence of a specific extracellular domain called the N-terminus transmembrane domain. OR7E155P is unique because it has a unique amino acid sequence at its N-terminus that is not found in any other GPCR.

OR7E155P has been shown to play a crucial role in the development and progression of neurological and psychiatric disorders. Studies have shown that individuals with certain genetic variations in the OR7E155P gene are at an increased risk of developing these disorders. For example, individuals with the OR7E155P gene that has a specific amino acid substitution, known as rs6920238, are reported to have an increased risk of developing Alzheimer's disease.

In addition to its role in disease, OR7E155P has also been shown to be a potential biomarker for several neurological and psychiatric disorders. Studies have shown that OR7E155P can be used as a potential biomarker for Alzheimer's disease, with higher levels of OR7E155P in the brain being associated with an increased risk of developing the disease. Similarly, OR7E155P has also been shown to be a potential biomarker for Parkinson's disease, with higher levels of OR7E155P in the brain being associated with an increased risk of developing the disease.

OR7E155P has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of neurological and psychiatric disorders. For example, studies have shown that OR7E155P is involved in the regulation of the production of reactive oxygen species (ROS), which are highly reactive molecules that can cause damage to cellular components and contribute to the development of certain neurological and psychiatric disorders.

In conclusion, OR7E155P is a pseudogene that has been shown to play a crucial role in the development and progression of neurological and psychiatric disorders. Its unique amino acid sequence and its involvement in the regulation of cellular signaling pathways make it an attractive potential drug target and biomarker for the treatment of these disorders. Further research is needed to fully understand the role of OR7E155P in disease and to develop effective treatments.

Protein Name: Olfactory Receptor Family 7 Subfamily E Member 155 Pseudogene

The "OR7E155P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR7E155P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4 | ORC5 | ORC6 | Orexin receptor | Organic anion transporters (OATs) | Organic cation transporter | Origin recognition complex | ORM1 | ORM2 | ORMDL1 | ORMDL2 | ORMDL3 | OS9 | OSBP | OSBP2 | OSBPL10 | OSBPL11 | OSBPL1A | OSBPL2 | OSBPL3 | OSBPL5 | OSBPL6 | OSBPL7 | OSBPL8 | OSBPL9 | OSCAR | OSCP1 | OSER1 | OSER1-DT | OSGEP | OSGEPL1 | OSGEPL1-AS1 | OSGIN1